Overnight liver perfusion shifts transplants to daytime—safely

The University Medical Center Groningen (UMCG) in the Netherlands has delivered what transplant surgeons have long sought: a way to safely shift liver transplants from overnight emergencies to scheduled daytime procedures. Their study, published this month, confirms that livers preserved overnight via machine perfusion perform at least as well as those transplanted immediately or after short-term perfusion. The finding holds across all donor liver types—including extended-criteria organs often deemed higher-risk.

This isn’t about inventing new technology but optimizing existing tools. Machine perfusion, which pumps oxygenated fluid through organs outside the body, has been used for years in short bursts. The Dutch team’s contribution is proving it works overnight—long enough to turn a 3 a.m. scramble into a 9 a.m. surgery. For hospitals, that means better-staffed operating rooms and fewer exhausted teams. For patients, it could mean fewer delays when matching organs become available.

Yet the study’s real strength—and its constraint—lies in its design. This was a single-center analysis, not a randomized controlled trial (RCT). While the sample included 124 transplants (a robust number for this field), the lack of multi-site validation means regulatory bodies may demand more data before endorsing overnight perfusion as standard practice. The outcomes were statistically non-inferior, but non-inferiority isn’t superiority.

The clinical relevance here is immediate but narrow. Hospitals already using machine perfusion (a growing list, including U.S. centers) could adopt overnight protocols tomorrow—if they’re willing to bear the logistical and cost burdens. The UMCG team used a commercial perfusion system, which adds thousands per procedure. For cash-strapped health systems, that’s a tough sell without proof of long-term cost savings from fewer complications or shorter hospital stays.

What the study doesn’t answer is whether this shifts the needle for marginal livers. The inclusion of all donor types hints at potential, but the data don’t parse outcomes by organ quality. Could overnight perfusion salvage more extended-criteria livers, or does it merely reschedule the same pool of viable organs? That distinction matters: One is a workflow tweak; the other could expand the donor pool.

Nor does the research address the elephant in the room—organ shortage. Machine perfusion, no matter how optimized, can’t create more livers. It can only redistribute the timing of their use. The real bottleneck, as ever, remains supply. Still, for patients facing a transplant, the ability to schedule surgery during daylight hours—with a full surgical team and no middle-of-the-night risks—is no small thing.